product design

Helping Enable Discovery


Thank you to all who are diligently working on the front lines as we, a global community, fight the COVID-19 pandemic. Medical research is working hard to find effective therapeutics such as antiviral drugs including vaccines, peptide inhibitors, nucleoside analogues and monoclonal antibodies. Others are developing in vitro assays for research and clinical testing. BioTek is a registered medical device manufacturer of IVD and Research Use Only microplate readers, washers, dispensers, automated microscopes and imagers. These instruments help to accelerate and automate the processing of thousands of samples. Here you will find information on the solutions BioTek provides that can be used for COVID-19 related research.

Ask a Specialist

Contact us to discuss whether these solutions can aid in your research workflows and know that budgetary or shipping concerns can be mitigated during this important time. We will do everything possible to meet your needs and expedite high-need shipments. We are here to help!

Research & Assay Development

Serological research
PCR master mix dispensing

General Virology Applications

Viral Growth/Titration
Viral Replication Kinetics
Viral Detection

Therapeutic Development

Vaccine Development
Humoral Response
Antivirals/Small Molecules



Cellular Host Response

Cellular Tropism
Cellular Immune Response
Soluble Immune Response
Cell Death Detection & Modality

Animal Models of Infection

Soluble Immune Response
Cellular Immune Response

Related Webinars


Virology and Infectious Disease Virtual Conference - On Demand

MIMETAS and BioTek Instruments: A Toolbox to Dissect the Vascular Impact of COVID-19

Presenters: Kristin Bircsak, PhD, Principal Scientist, MIMETAS and Kristen N. Peters Olson, Ph.D. (Molecular Microbiology and Immunology), Imaging Specialist, Field Applications Scientist, BioTek Instruments

This collaborative webinar provides a toolbox of MIMETAS products and relevant BioTek imaging and detection applications to dissect and improve our understanding of the interplay between SARS-CoV-2 and vasculature.



Understanding the Enemy: An Applied Review of SARS-CoV-2 and COVID-19 - On Demand

Presenter: Dr. Kristen Peters Olson, Field Applications Scientist

This webinar reviews the broad range of research techniques and assay formats employed to develop effective treatments and advance clinical testing. Content covers general virology applications, cellular host response studies, animal models of infection, and therapeutic development.



Customer Spotlights


Developing a Serological Test to Detect SARS-CoV-2 Clues (405 LS)

There was no shortage of virology projects in Dr. Florian Krammer’s busy laboratory at the Icahn School of Medicine at Mount Sinai in New York City. The team was hard at work developing a universal influenza virus vaccine that could be administered two or three times in a lifetime instead of yearly. They were developing and testing monoclonal antibodies that bind to surface proteins of the influenza virus and other viruses. They were also taking a very close look at an influenza virus surface glycoprotein, called neuraminidase, to improve vaccine effectiveness.




Live SARS-CoV-2 Research: Interlocking Pieces Working Together (MultiFlo FXCytation 1BioStack, 405 LS)

When Dr. Robert Davey started researching Ebola virus drug development at the University of Texas Medical Branch (UTMB) at Galveston back in 2008, he had no idea just how keenly his work would prepare him to play a pivotal role in researching treatments for a very different global pandemic. In fact, a number of pieces fit together to support his current role in screening small molecule compounds that may be used in the fight against SARS-CoV-2, the novel coronavirus that causes COVID-19.




BioTek instruments featured on NOVA:

Decoding COVID-19: Scientists race to understand and defeat the coronavirus behind the COVID-19 pandemic
Aired May 13, 2020
Vaccine Research and BioTek @ 32:37 – 35:45
-    NOVA/PBS (Documentary)





If you are a BioTek customer and need support with your instrumentation or software, specifically in regard to serological research for SARS-CoV-2, please don’t hesitate to reach out. Our teams are ready and available to prioritize your support request.


Click here for BioTek's customer statement on COVID-19 coronavirus.